Illumina's divestiture of GRAIL boosts financials, while strong gross margins and DNA sequencing growth drive potential. See ...

Illumina (NASDAQ:ILMN) stock dips as Scotiabank downgrades. However, peers Danaher (DHR) stock and Thermo Fisher (TMO) stock win upgrades. Read more here.

Illumina’s first quarter results reflected ongoing challenges in the global genomics market, as the company’s performance ...

Shares of Illumina Inc. (NASDAQ:ILMN) dropped 3.8% on Wednesday after Citi downgraded the stock from Neutral to Sell, warning ...

The year kicked off with a handful of acquisitions from top companies. Dealmaking has since slowed amid economic uncertainty ...

Introduction In vitro diagnostics (IVD) refers to medical tests performed outside the human body, typically in laboratories or at the point of ...

Market Growth Driven by Declining Sequencing Costs, Rising Prevalence of Genetic Disorders, Expanding Clinical Applications, and Technologica ...

The first China manufacturing site of Illumina, a global leader in DNA sequencing and array-based technologies, commenced operations recently.